CanBas Co., Ltd. (TYO:4575)
Japan · Delayed Price · Currency is JPY 837.00
+19.00 (2.32%)
Aug 27, 2026, 12:44 PM JST
CanBas Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
14
Market Cap
15.63B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | - | - | - |
| Jun 30, 2025 | - | - | - |
| Jun 30, 2024 | - | - | - |
| Jun 30, 2023 | - | - | - |
| Jun 30, 2022 | - | - | - |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| RaQualia Pharma | 3.90B |
| ReproCELL | 2.30B |
| Immuno-Biological Laboratories | 1.08B |
| AnGes | 962.00M |
| SUSMED,Inc. | 497.00M |
| Stella Pharma | 323.00M |
| Nano Holdings | 202.00M |
| CellSeed | 161.00M |